March 2024

February 2024

Maximizing Liquid Biopsy Sensitivity through the Power of DNA-Binding Antibodies

2024-04-24T10:33:09-04:00February 1st, 2024|Webinars|

In this webinar, you will learn: Non-Invasive Liquid Biopsies: Cell-free DNA as a key analyte for non-invasive liquid biopsies for cancer diagnosis and monitoring. Enhanced Cell-Free DNA Recovery: Strategies to improve cell-free DNA recovery, including the use of DNA priming agents like DNA-binding monoclonal antibodies. Fc-Domain Engineering: The process of engineering [...]

March 2022

First Immunoassay for Measuring Isoaspartate in Human Serum Albumin

2024-04-24T10:57:11-04:00March 25th, 2022|Case Studies|

The ongoing pandemic has reinforced the need for in vitro diagnostics to globally surveille emerging pathogens and provide better medical care. In particular, immunoassays are favoured due to their affordability, ease, and speed. Nevertheless, the combination of rapidly evolving pathogens, and more complex diseases resulting from increasing life expectancy worldwide require more sensitive and specific immunoassays in the nick of time. To increase sensitivity, immunoassay development can benefit from exploiting industry-leading technologies such as de novo protein sequencing.

March 2021

The Underlying Cause of Medical Diagnostic Invalidation

2024-04-24T10:53:24-04:00March 23rd, 2021|Whitepapers|

In-vitro diagnostics (IVDs) are one of the most commonly used tools to diagnose conditions and guide treatment decisions and are often considered the “silent champion” of healthcare. They work by detecting the absence or presence of particular markers or by measuring the concentration of analytes or specific substances.